- Report
- March 2025
- 186 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- February 2025
- 174 Pages
Global
From €5174EUR$5,450USD£4,364GBP
- Report
- November 2024
- 350 Pages
Global
From €3793EUR$3,995USD£3,199GBP
- Report
- December 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- December 2024
- 200 Pages
Global
From €3560EUR$3,750USD£3,003GBP
- Report
- May 2023
- 230 Pages
Global
From €4556EUR$4,799USD£3,843GBP
- Report
- January 2022
- 242 Pages
Global
From €4556EUR$4,799USD£3,843GBP
From €4509EUR$4,750USD£3,804GBP
- Report
- December 2023
- 390 Pages
Global
From €3797EUR$4,000USD£3,203GBP
- Report
- November 2024
- 95 Pages
Global
From €3500EUR$3,949USD£3,056GBP
- Book
- March 2024
- 544 Pages
- Book
- August 2023
- 368 Pages
- Book
- February 2015
- 408 Pages

The Bioimaging market is a subset of the biotechnology industry that focuses on the development and use of imaging technologies to visualize biological processes. This includes the use of microscopy, spectroscopy, and other imaging techniques to observe and analyze biological systems. Bioimaging is used to study the structure and function of cells, tissues, and organs, as well as to monitor the effects of drugs and other treatments. It is also used to diagnose and monitor diseases, such as cancer, and to study the effects of environmental factors on living organisms.
Bioimaging technologies are used in a variety of industries, including pharmaceuticals, medical diagnostics, and research. Companies in the Bioimaging market include Nikon, Olympus, Carl Zeiss, Bruker, PerkinElmer, Thermo Fisher Scientific, and Hitachi. Show Less Read more